Phibro Animal Health (PAHC) Receivables - Other (2013 - 2014)
Phibro Animal Health's (PAHC) quarterly Receivables - Other came in at $5.4 million in Q1 2014, little changed quarter-over-quarter from $5.4 million in Q2 2013.
Phibro Animal Health (PAHC) Receivables - Other (2013 - 2014) Analysis & Trends
Phibro Animal Health's Receivables - Other history runs 2 years deep, the most recent figure standing at $5.4 million for Q1 2014.
- On a quarterly basis, Receivables - Other changed N/A year-over-year to $5.4 million in Q1 2014; TTM through Mar 2014 was $5.4 million, a N/A change from a year earlier, with the FY2013 full-year figure at $5.4 million, changed N/A from the prior year.
- Receivables - Other held at $5.4 million in Q1 2014 per PAHC's latest filing, from $5.4 million in the prior quarter.
- Across five years, Receivables - Other topped out at $5.4 million in Q2 2013 and bottomed at $5.4 million in Q2 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | 5.35 Mn |
| Mar 31, 2014 | 5.35 Mn |
| Jun 30, 2013 | 5.35 Mn |
| Jun 30, 2013 | 5.35 Mn |